Immunotherapy-Responsive Post COVID-19 Central Nervous System Inflammatory Syndrome, a Case Report
Background: COVID 19 virus can infect the central and peripheral nervous system with or without other systemic manifestations of infection....
Case Report: Lama-2 Related Muscular Dystrophy Mimicking Multiple Sclerosis
Background: There is increased prevalence of genetic testing within the field of neurology and provider awareness of genetic conditions...
Bad Lettuce? Frozen Vegetables? Undercooked Steak? Case Report of Systemic Listeria Monocytogenes Infection in a Patient on Dimethyl Fumarate
Background: The use of disease modifying treatments (DMTs) in multiple sclerosis (MS) has been well studied and has shown to reduce...
Identifying and Treating Steroid-Induced Psychosis in MS Patients Using Quetiapine
Background: High-dose corticosteroids (CS) (1g IV methylprednisolone or 1250 mg oral prednisone for 3-5 days) is the most common treatment...
COVID-19 in Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease Patients in North America
Background: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raised...
Cogeval in the Real World: Feasibility, Implementation, and Practical Implications
Background: Cognitive dysfunction in multiple sclerosis (MS) patients is common, and routine/efficient screening for cognitive dysfunction...